2026 Medicare Changes: Rates, Drug Pricing, and Advantage Plans
Failed to add items
Add to basket failed.
Add to Wish List failed.
Remove from Wish List failed.
Follow podcast failed
Unfollow podcast failed
2026 Medicare Changes: Rates, Drug Pricing, and Advantage Plans
-
Narrated by:
-
By:
About this listen
Send us a text
The provided sources primarily detail official regulatory updates and budgetary plans for the 2026 fiscal and calendar years. A comprehensive announcement from the Centers for Medicare & Medicaid Services (CMS) outlines finalized payment rates, risk adjustment models, and Star Ratings criteria for Medicare Advantage and Part D prescription drug plans. These technical documents explain how the government will adjust funding benchmarks and quality assessments to ensure accurate provider compensation and plan performance. Simultaneously, the Government Accountability Office (GAO) presents its performance plan, which emphasizes its role as a congressional watchdog dedicated to auditing federal spending and improving government efficiency. Together, these materials highlight the administrative and oversight frameworks governing major federal health programs and general agency operations. The combined texts serve as a roadmap for federal healthcare policy and government accountability for the upcoming year.